We’re definitely into long term investing, but some companies are simply bad investments over any time frame. We really hate to see fellow investors lose their hard-earned money. Spare a thought for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Shares in Small-Cap Star Idera Pharmaceuticals (IDRA) are up today following the announcement of an agreement with Abbott Laboratories (ABT) to develop a companion diagnostics test for use in clinical ...
BioCryst Pharmaceuticals Inc. and Idera Pharmaceuticals Inc. announced early Monday plans to merge into a rare disease company. Shares of both companies were halted in premarket trade. Under the deal, ...
Idera Pharmaceuticals is eyeing up peak sales of $650 million from Aceragen's three lead programs. (cagkansayin/GettyImages) With cash expected to run out within a ...
Idera Pharmaceuticals Inc IDRA announced that the phase II clinical study, evaluating its pipeline candidate, IMO-8400, for dermatomyositis - a rare inflammatory skin disease - fell short of meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results